YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway

MLA

Xin Li, et al. “YY1-Induced Upregulation of LncRNA-ARAP1-AS2 and ARAP1 Promotes Diabetic Kidney Fibrosis via Aberrant Glycolysis Associated with EGFR/PKM2/HIF-1α Pathway.” Frontiers in Pharmacology, vol. 14, Feb. 2023. EBSCOhost, https://doi.org/10.3389/fphar.2023.1069348.

APA

Xin Li, Tian-Kui Ma, Min Wang, Xiao-Dan Zhang, Tian-Yan Liu, Yue Liu, Zhao-Hui Huang, Yong-Hong Zhu, Shuang Zhang, Li Yin, Yan-Yan Xu, Hong Ding, Cong Liu, Hang Shi, & Qiu-Ling Fan. (2023). YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1069348

Chicago

Xin Li, Tian-Kui Ma, Min Wang, Xiao-Dan Zhang, Tian-Yan Liu, Yue Liu, Zhao-Hui Huang, et al. 2023. “YY1-Induced Upregulation of LncRNA-ARAP1-AS2 and ARAP1 Promotes Diabetic Kidney Fibrosis via Aberrant Glycolysis Associated with EGFR/PKM2/HIF-1α Pathway.” Frontiers in Pharmacology 14 (February). doi:10.3389/fphar.2023.1069348.